UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (33) 33
life sciences & biomedicine (33) 33
science & technology (33) 33
gastroenterology & hepatology (23) 23
female (21) 21
adult (20) 20
male (20) 20
middle aged (18) 18
aged (13) 13
antiviral agents - therapeutic use (12) 12
biological and medical sciences (12) 12
medical sciences (10) 10
genotype (9) 9
hepacivirus - genetics (9) 9
infectious diseases (9) 9
liver transplantation (9) 9
hepatitis b (8) 8
hepatitis c, chronic - drug therapy (8) 8
human viral diseases (8) 8
viral diseases (8) 8
analysis (7) 7
gastroenterology and hepatology (7) 7
health aspects (7) 7
hepatitis (7) 7
treatment outcome (7) 7
viral hepatitis (7) 7
abridged index medicus (6) 6
antiviral agents (6) 6
antiviral agents - adverse effects (6) 6
united states (6) 6
clinical trials (5) 5
drug therapy, combination (5) 5
general & internal medicine (5) 5
hepatitis b e antigens - blood (5) 5
hepatitis b, chronic - drug therapy (5) 5
hepatitis c (5) 5
interferon-alpha - therapeutic use (5) 5
liver (5) 5
liver diseases (5) 5
medicine, general & internal (5) 5
phylogeny (5) 5
pregnancy (5) 5
prospective studies (5) 5
receptors, dopamine - metabolism (5) 5
retrospective studies (5) 5
ribavirin - therapeutic use (5) 5
transplantation (5) 5
young adult (5) 5
animals (4) 4
cirrhosis (4) 4
dogs (4) 4
double-blind method (4) 4
drug therapy (4) 4
fundamental and applied biological sciences. psychology (4) 4
genotypes (4) 4
hepatitis b virus - genetics (4) 4
hepatitis c virus (4) 4
hepatitis c, chronic - virology (4) 4
hepatology (4) 4
lamivudine (4) 4
polyethylene glycols - therapeutic use (4) 4
recurrence (4) 4
research (4) 4
ribavirin (4) 4
rna, viral - blood (4) 4
time factors (4) 4
viral load (4) 4
virology (4) 4
adolescent (3) 3
aged, 80 and over (3) 3
antiviral agents - administration & dosage (3) 3
biopsy (3) 3
brain - metabolism (3) 3
care and treatment (3) 3
corpus striatum - metabolism (3) 3
disease progression (3) 3
dna, viral - blood (3) 3
fibrosis (3) 3
gastroenterology. liver. pancreas. abdomen (3) 3
general aspects (3) 3
genetic aspects (3) 3
hepatitis b virus - immunology (3) 3
hepatitis b, chronic - blood (3) 3
hepatitis b, chronic - immunology (3) 3
hepatitis b, chronic - virology (3) 3
hepatitis c - therapy (3) 3
hepatitis c - virology (3) 3
infections (3) 3
interferon (3) 3
lamivudine - therapeutic use (3) 3
liver cancer (3) 3
liver cirrhosis (3) 3
liver cirrhosis - etiology (3) 3
liver failure - surgery (3) 3
liver. biliary tract. portal circulation. exocrine pancreas (3) 3
molecular sequence data (3) 3
other diseases. semiology (3) 3
patients (3) 3
pharmacology. drug treatments (3) 3
pregnant women (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet infectious diseases, ISSN 1473-3099, 2013, Volume 13, Issue 5, pp. 401 - 408
Infectious Disease | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Viral hepatitis | Infectious diseases | Liver. Biliary tract. Portal circulation. Exocrine pancreas | Pharmacology. Drug treatments | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Immunomodulators | Other diseases. Semiology | Recombinant Proteins - therapeutic use | Uridine Monophosphate - administration & dosage | Nausea - chemically induced | Humans | Middle Aged | Hepatitis C, Chronic - virology | Hepacivirus - pathogenicity | Male | Secondary Prevention | Polyethylene Glycols - therapeutic use | Young Adult | Time Factors | Ribavirin - administration & dosage | Adult | Female | Headache - chemically induced | Uridine Monophosphate - therapeutic use | Double-Blind Method | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | RNA, Viral - analysis | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Polyethylene Glycols - administration & dosage | Recombinant Proteins - administration & dosage | Interferon-alpha - administration & dosage | Drug Therapy, Combination - methods | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Adolescent | Liver Cirrhosis - pathology | Aged | Hepacivirus - classification | Sofosbuvir | Care and treatment | Protease inhibitors | Proteases | Gastrointestinal diseases | Clinical trials | Product development | Genetic aspects | Interferon | Hepatitis C | Health aspects | Liver cirrhosis | Viral antigens | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 06/2011, Volume 364, Issue 25, pp. 2405 - 2416
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antiviral agents | General aspects | Viral hepatitis | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Antibiotics. Antiinfectious agents. Antiparasitic agents | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Polyethylene Glycols - adverse effects | Male | RNA, Viral - blood | Recombinant Proteins | Oligopeptides - adverse effects | Polyethylene Glycols - therapeutic use | Viral Load | Oligopeptides - therapeutic use | Serine Proteinase Inhibitors - therapeutic use | Young Adult | Serine Proteinase Inhibitors - adverse effects | Adult | Female | Drug Therapy, Combination | Hepacivirus - isolation & purification | Double-Blind Method | Antiviral Agents - therapeutic use | Interferon-alpha - therapeutic use | Logistic Models | Hepatitis C, Chronic - drug therapy | Sequence Analysis, DNA | Antiviral Agents - adverse effects | Aged | Interferon-alpha - adverse effects | Peginterferon alfa-2b | Patient outcomes | Genetic aspects | Hepatitis C | Drug therapy | Comparative analysis | Health aspects | Fees & charges | Antiretroviral drugs | Liver diseases | Clinical trials | Chronic infection | Employees | Infections | Proteinase inhibitors | Genomes | Ribonucleic acid--RNA | Patients | Ribavirin | Liver cancer | Genotype & phenotype | Hepatitis | Skin | Interferon | Genotypes | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article